Diagnosis of ascites in infants and children by history, examination and investigations

Ascites

Diagnosis of Ascites in Infants and Children

Diagnosis of ascites in infants and children fromega age of 1month to 18 year

Asmaa abo bakr Ahmed

Doctor

Assiut University

Neonatal Hyperbilirubinemia

Shoklo Malaria Research Unit

Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)

A Prospective Cohort Study on the Etiology of Neonatal Hyperbilirubinemia in a Migrant and Refugee Population on the Thai-Myanmar Border

Establish the causes contributing to the development of neonatal hyperbilirubinemia in this population, including a detailed description of the clinical course of neonates with neonatal hyperbilirubinemia.

University of Oxford

40 micrograms/kg every other day (QOD) x 3 every 4 weeks in patients with chronic lymphocytic leukemia, the most prevalent form of adult leukemia.

LMB-2 in Chronic Lymphocytic Leukemia

Sex: Female, Male

Ethnicity (NIH/OMB)

Race (NIH/OMB)

Region of Enrollment

Response is measured by the 1996 National Cancer Institute (NCI) Working Group Criteria (NCIWG). Complete response is defined as no hepatomegaly, splenomegaly, or lymphadenopathy by physical examination and appropriate radiographic techniques. Lymph nodes must resolve to <1.0cm of 1-1.5cm at baseline, or <1.5cm if >1.5cm at baseline. Partial response is >=50% decrease in peripheral blood lymphocytes count from the pretreatment baseline value. Progressive disease is >=50% increase in the sum of the products of the greatest perpendicular dimensions of a t least 2 lymph nodes on two consecutive examinations 2 weeks apart (at least 1 node must be >=2cm) or appearance of new palpable lymph nodes. Stable disease is characterized by not meeting the above criteria. For additional details about the NCIWG, see the protocol link module.

Response Rate

Here is the number of participants with adverse events. For the detailed list of adverse events see the adverse event module.

Number of Participants With Adverse Events

Overall Study

Robert J. Kreitman, M.D.

Leukemia

Lymphocytic

Chronic

40 micrograms/kg every other day (QOD) x 3 every 4 weeks

hepatomegaly/albumin

Diagnosis of Ascites in Infants and Children

Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia

Najkompletnija baza ljekovitog bilja potpomognuta naukom